Skip to main content
CNTA logo
CNTA
(NASDAQ)
Centessa Pharmaceuticals plc
$39.70-- (--)
Loading... - Market loading

Centessa Pharmaceuticals (CNTA) Stock Price & Financial Analysis

Centessa Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$39.60 - $39.70
52-Week High$40.26
52-Week Low$10.95
Open$39.60
Volume786.21K
Average Volume (3M)2.00M
Market Cap5.38B
Shares Outstanding135.72M
Price to Sales (P/S)358.20
Price to Book (P/B)10.20
EV/EBITDA-25.03
Revenue (TTM)15.00M
Net Income (TTM)-197.53M
Free Cash Flow (TTM)-194.12M
EPS (TTM)$-1.47
Profit Margin-1316.88%
Operating Margin-1384.61%
Return on Equity (ROE)-37.49%
Debt to Equity0.21
50-Day MA$34.74
200-Day MA$26.00
52-Week Change201.06%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Centessa Pharmaceuticals

What is the current stock price for CNTA?

As of the latest trading session, CNTA stock trades at $39.70. The 52-week range is $10.95–$40.26, with a day range of $39.60–$39.70.

What is the P/E ratio for CNTA?

The P/E ratio (Price-to-Earnings) for CNTA is shown in the Key Statistics section. This valuation metric helps compare Centessa Pharmaceuticals plc to industry peers.

Does CNTA pay dividends?

Centessa Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CNTA?

Based on 9 analysts, the consensus for CNTA is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CNTA?

Centessa Pharmaceuticals's market capitalization is $5.39B, classifying it as a mid-cap company. Centessa Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.